drugset / Trial / NCT00731861
Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate PTK787, a new oral drug that stops blood vessel development, in combination with Paclitaxel in patients with advanced solid tumors.
Timeline
- Start
- 2005-05
- Primary completion
- 2008-09
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | vatalanib | Small molecule | — | Oral |
| Background | Paclitaxel | Small molecule | — | — |